TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 2 | 3 | 3 | -9 | -7 | -16 | -4 |
| S | %wins | 0 | 0 | 33 | 67 | 100 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/16 15:34 | 12/2/16 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Elagin Vecheslav A | OH | O | EVP,Rese | S | -136 | 17.30 | 6 | -8 | -13 | 53 | D | 13 | -6 | -9 | -9 | 5 | 1 | 1 | 2 | 2 | 3 | 2 | -24 | ||
12/10/15 12:59 | 12/9/15 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Elagin Vecheslav A | OH | O | EVP,Rese | S | -148 | 19.75 | 4 | -8 | -12 | 55 | D | -12 | 21 | 9 | 13 | 6 | 3 | 1 | 1 | 1 | 2 | -6 | 6 | 0 | -5 |
12/6/13 13:34 | 12/5/13 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Elagin Vecheslav A | OH | O | EVP,Rese | S | -98 | 23.74 | 4 | -4 | -8 | 51 | D | 39 | 21 | 13 | 3 | -3 | -3 | -1 | -2 | 2 | 3 | 13 | -8 | -13 | -26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |